Teva Doubles Down On Alvotech Biosimilars Partnership
Invests $40m, Adds Two More Biosimilars To Deal And Actively Supports Quality Efforts
• By David Wallace
Teva will get more actively involved in Alvotech’s quality processes • Source: Shutterstock 
